AMRN: Amarin Corporation plc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMRN: Amarin Corporation plc

AMRN 15.67

0.0%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: Joe Dancy	12/3/2000 10:42:55 AM
	Read Replies (1) of 49

Amarin recently announced that revenues were up over 200% last quarter, and at a presentation to analysts in Paris they stated that their goal is revenues of $100 million in fiscal year 2003, up from maybe $20 million now. And they have a target market capitalization of $500 million - a seven fold increase from current price levels - in the same time period. Management has a strong influence from Elan - who has rights to buy 70%+ of the company by excercising warrants. AMRN management's comments on their strategy and products made at the SG Cowen Paris conference can be accessed at sgcowen.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext